No Data
No Data
Express News | Viracta Therapeutics Inc - Receives Notice of Non-Compliance From Nasdaq
Viracta Therapeutics Is Maintained at Outperform by RBC Capital
RBC Cuts Price Target on Viracta Therapeutics to $2 From $4, Keeps Outperform, Speculative Risk
Viracta Therapeutics | 10-Q: Q3 2024 Earnings Report
Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Viracta Therapeutics Reports Q3 EPS (27c) Vs (33c) Last Year
No Data
No Data
105642463xu : $KULR Technology (KULR.US)$
Jaguar8 OP 105642463xu : Yup its on my watchlist
Rosscco : Thanks for the tip !
Adria87 : Thank You for the tip
baqklin : not a good play if 66% is moved to dark pool?
View more comments...